ACELRX PHARMACEUTICALS INC
ACELRX PHARMACEUTICALS INC (ACRX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 315 transactions totaling $76.5M, demonstrating a bullish sentiment with $31.0M in net insider flow. The most recent transaction on Dec 13, 2023 involved a purchase of 10,000 shares valued at $7.3K.
ACRX Insider Activity Summary
Who Is Buying ACRX Stock?
No significant insider buying has been recorded for ACRX in the recent period.
Who Is Selling ACRX Stock?
No significant insider selling has been recorded for ACRX in the recent period.
Is ACELRX PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACRX is bullish with an Insider Alignment Score of 70/100 and a net flow of $31.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ACRX Frequently Asked Questions
Understanding ACRX Insider Activity
Insider trading at ACELRX PHARMACEUTICALS INC (ACRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading ACRX stock, having executed 315 transactions in the past 90 days. The most active insider is Mark A. Wan (Executive), who has made 17 transactions totaling $12.4M.
Related Tools
Track ACELRX PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at ACRX file new Form 4 transactions